During the Q2 earnings call, UPS said it expects Q3 average daily volume to decline mid-single digits, reflecting a seasonal decline as well as the impact of this year's Amazon glide down, which completed in June
Your experience may be influenced by several factors, including nutrition, stress levels, sleep quality, underlying health conditions, medications, and overall lifestyle
This new avenue has yet to see a standout success, with Orforglipron emerging as a leading contender, showing promising results in blood sugar control and weight management according to clinical trials [14][15]
But Zepbound is FDA-approved and available today, while retatrutide remains investigational and is not yet on the market